https://ift.tt/2NOtvlg support@endlesssupplies.biz (Endless Supplies .Biz) October 18, 2018 at 01:03PM
Thursday, October 18, 2018
FDA snubs Novartis bid to repurpose inflammation drug for heart attacks
The U.S. Food and Drug Administration has rejected Novartis's bid to repurpose a drug now approved for rare inflammatory diseases to be used in a group of heart attack survivors, the Swiss drugmaker said on Thursday.
https://ift.tt/2NOtvlg support@endlesssupplies.biz (Endless Supplies .Biz) October 18, 2018 at 01:03PM
https://ift.tt/2NOtvlg support@endlesssupplies.biz (Endless Supplies .Biz) October 18, 2018 at 01:03PM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment